Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours Β· Estimated delivery Aug 23 - Aug 28
To date, Phase 3 clinical trial data have also shown significant weight-loss outcomes, including up to 28.7% average body weight loss at 68 weeks in one obesity trial and 16.8% average weight loss at 40 weeks in adults with type 2 diabetes, with additional Phase 3 readouts still expected throughout 2026
Storage after mixing determines how long solutions remain usable
12+ months: Weight loss peaks around 65 weeks, then stabilizes
If these occur, reduce concentration or frequency immediately
US$ 20.63
US$ 25.37
US$ 21.46
US$ 27.25
